C12N 2710/20041
Use of virus, viral particle or viral elements as a vector
C12N2710/20041 (Use of virus, viral particle or viral elements as a vector) appears on 31 US grants and 48 published applications in this corpus.
Search patents in C12N- Granted patents
- 31
- Published applications
- 48
- Assignees
- 38
- Inventors
- 104
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 3 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 5 |
| 2012 | 2 | 4 |
| 2013 | 0 | 1 |
| 2014 | 2 | 2 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 2 |
| 2020 | 0 | 5 |
| 2021 | 1 | 4 |
| 2022 | 1 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 1 |
| 2025 | 2 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/20043Viral genome or elements thereof as genetic vectorIndexing code23
- C12N 2710/20042Virus or viral particle as vehicleIndexing code5
- C12N 2710/20045Special targeting system for viral vectorsIndexing code2
- C12N 2710/20044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
Recent patents
- Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors31 Mar 2026US 12,589,165 B2Aura Biosciences, Inc.
- Recombinant pseudocowpoxvirus5 Aug 2025US 12,377,142 B2Transgene S. A.
- Probe for universal detection of circulating tumor cells21 Jan 2025US 12,203,935 B2University of Houston System
- Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses2 Apr 2024US 11,944,677 B2Verimmune Inc.
- Non-human papillomaviruses for gene delivery in vitro and in vivo2 Apr 2024US 11,946,048 B2Angewandten Forschung E.V.
- Probe for universal detection of circulating tumor cells29 May 2025US 2025/0172561 A1
- Probe for universal detection of circulating tumor cells22 May 2025US 2025/0164490 A1
- Glucagon-like-peptide-2 (glp-2) analogues17 Apr 2025US 2025/0122260 A1Zealand Pharma A/S
- Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses28 Nov 2024US 2024/0390473 A1Verimmune Inc.
- Intratumoral vaccination28 Sep 2023US 2023/0303659 A1Heat Biologics, Inc.
Most cited
By later US patents
- Recombinant DNA process utilizing a papilloma virus DNA as a vector284US 4,419,446 AThe United States of America as represented by the Department of Health and Human Services · 1983
- Mammalian metallothionein promoter system224US 4,601,978 AThe Regents of the University of California · 1986
- Episomal vector systems and related methods81US 5,674,703 A1997
- Human papilloma virus vectors37US 6,399,383 B1Maxygen, Inc. · 2002
- Vectors for DNA immunization against cervical cancer28US 6,235,523 B1Connaught Laboratories Limited · 2001